The global Gabapentin market was valued at $XX million in 2018, and Global Research View analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Gabapentin from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Gabapentin market.

Leading players of Gabapentin including:
Pfizer
Depomed
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike

Market split by Type, can be divided into:
Capsule
Tablet

Market split by Application, can be divided into:
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others

Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel

Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America Brazil, Argentina, Colombia and Chile etc.)
Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

Table of Contents

Chapter 1 Gabapentin Market Overview
1.1 Gabapentin Definition
1.2 Global Gabapentin Market Size Status and Outlook (2021-2026)
1.3 Global Gabapentin Market Size Comparison by Region (2021-2026)
1.4 Global Gabapentin Market Size Comparison by Type (2021-2026)
1.5 Global Gabapentin Market Size Comparison by Application (2021-2026)
1.6 Global Gabapentin Market Size Comparison by Sales Channel (2021-2026)
1.7 Gabapentin Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Gabapentin Market Segment Analysis by Player
2.1 Global Gabapentin Sales and Market Share by Player (2016-2018)
2.2 Global Gabapentin Revenue and Market Share by Player (2016-2018)
2.3 Global Gabapentin Average Price by Player (2016-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Gabapentin Market Segment Analysis by Type
3.1 Global Gabapentin Market by Type
3.1.1 Capsule
3.1.2 Tablet
3.2 Global Gabapentin Sales and Market Share by Type (2013-2018)
3.3 Global Gabapentin Revenue and Market Share by Type (2013-2018)
3.4 Global Gabapentin Average Price by Type (2013-2018)
3.5 Leading Players of Gabapentin by Type in 2018
3.6 Conclusion of Segment by Type
Chapter 4 Gabapentin Market Segment Analysis by Application
4.1 Global Gabapentin Market by Application
4.1.1 Epilepsy
4.1.2 Neuropathic Pain
4.1.3 Restless Legs Syndrome
4.1.4 Others
4.2 Global Gabapentin Sales and Market Share by Application (2013-2018)
4.3 Leading Consumers of Gabapentin by Application in 2018
4.4 Conclusion of Segment by Application
Chapter 5 Gabapentin Market Segment Analysis by Sales Channel
5.1 Global Gabapentin Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Gabapentin Sales and Market Share by Sales Channel (2013-2018)
5.3 Leading Distributors/Dealers of Gabapentin by Sales Channel in 2018
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Gabapentin Market Segment Analysis by Region
6.1 Global Gabapentin Market Size and CAGR by Region (2021-2026)
6.2 Global Gabapentin Sales and Market Share by Region (2013-2018)
6.3 Global Gabapentin Revenue and Market Share by Region (2013-2018)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Gabapentin Market Share by Type
6.4.3 North America Gabapentin Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Gabapentin Market Share by Type
6.5.3 Europe Gabapentin Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Gabapentin Market Share by Type
6.6.3 Asia-Pacific Gabapentin Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Gabapentin Market Share by Type
6.7.3 South America Gabapentin Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.7.7 Chile
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Gabapentin Market Share by Type
6.8.3 Middle East & Africa Gabapentin Market Share by Application
6.8.4 Egypt
6.8.5 Saudi Arabia
6.8.6 South Africa
6.8.7 Nigeria
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Gabapentin Players
7.1 Pfizer
7.1.1 Company Snapshot
7.1.2 Product/Business Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 Strategy and SWOT Analysis
7.2 Depomed
7.3 TEVA
7.4 Mylan
7.5 Arbor Pharma
7.6 Novartis
7.7 Apotex
7.8 Sun Pharmaceutical
7.9 Aurobindo Pharma
7.10 Intas
7.11 Amneal
7.12 Marksans Pharma
7.13 Glenmark
7.14 Alkem
7.15 Jiangsu Enhua
7.16 Jiangsu Hengrui
7.17 Sailike
Chapter 8 Upstream and Downstream Analysis of Gabapentin
8.1 Industrial Chain of Gabapentin
8.2 Upstream of Gabapentin
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Gabapentin
8.3.1 Leading Distributors/Dealers of Gabapentin
8.3.2 Leading Consumers of Gabapentin
Chapter 9 Development Trend of Gabapentin (2019-2028)
9.1 Global Gabapentin Market Size (Sales and Revenue) Forecast (2019-2028)
9.2 Global Gabapentin Market Size and CAGR Forecast by Region (2019-2028)
9.3 Global Gabapentin Market Size and CAGR Forecast by Type (2019-2028)
9.4 Global Gabapentin Market Size and CAGR Forecast by Application (2019-2028)
9.5 Global Gabapentin Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification

Share This Report

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Payment Mode

About This Report

Category
Report ID92531
CategoryPharma & Healthcare
Published on21-Jun
Publisher NameGlobal Research View

Why us

We are a dynamic team of industry researchers and provide efficient and effective solutions

with trusted and validated data points

  • We offer seamless support at pre and post-sales stage to guide our clients in crucial and strategic business decision plans
  • Innovative research techniques and approaches are implemented to offer key strategic insights
  • Our mission is to offer next to accurate information on fast evolving and dynamic market situations to boost capitalization and revenue acquisition
  • From SMEs to Fortune 500 companies we are the decision support system
  • Fewer assumptions and more precise analysis to foster accurate results
  • We completely believe in insights-driven and data-driven research approach
  • Highlighting forecast on investment feasibility, strategic mergers and acquisitions across       developed, developing and niche markets



REPORT CATEGORIES